Sperm DNA integrity in testicular cancer patients

Human Reproduction

Volumn 21, Issue 12, 2006, Pages 3199-3205

  Ståhl, Olof ^a   Eberhard, J ^a   Jepson, K ^a   Spano, M ^b   Cwikiel, M ^a   Cavallin Stahl E ^a   Giwercman, A ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b ENEA C R CASACCIA   (Italy)

Author keywords

Chemotherapy; Radiotherapy; SCSA; Sperm DNA; Testicular cancer; TUNEL

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DNA; DNA FRAGMENT; ETOPOSIDE; VINBLASTINE;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CHROMATIN STRUCTURE; CONTROLLED STUDY; DNA DAMAGE; DNA DETERMINATION; DNA STRAND BREAKAGE; FERTILIZATION; GERM CELL TUMOR; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MALE GENITAL SYSTEM SURGERY; MALE INFERTILITY; NICK END LABELING; POSTOPERATIVE PERIOD; SEMEN ANALYSIS; SPERMATOZOON COUNT; TESTIS CANCER; TREATMENT OUTCOME;

EID: 33751357064     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del292     Document Type: Article

References (41)

1. Blatt J (1999) Pregnancy outcome in long-term survivors of childhood cancer. Med Pediatr Oncol 33,29-33.
2. Brinkworth MH (2000) Paternal transmission of genetic damage: Findings in animals and humans. Int J Androl 23,123-135.
3. Bungum M, Humaidan P, Spano M, Jepson K, Bungum L and Giwercman A (2004) The predictive value of sperm chromatin structure assay (SCSA) parameters for the outcome of intrauterine insemination, IVF and ICSI. Hum Reprod 19,1401-1408.
4. Carrell DT, Liu L, Peterson CM, Jones KP, Hatasaka HH, Erickson L and Campbell B (2003) Sperm DNA fragmentation is increased in couples with unexplained recurrent pregnancy loss. Arch Androl 49,49-55.
5. Cherry SM, Hunt PA and Hassold TJ (2004) Cisplatin disrupts mammalian spermatogenesis, but does not affect recombination or chromosome segregation. Mutat Res 564,115-128.
6. Cram DS, Ma K, Bhasin S, Arias J, Pandjaitan M, Chu B, Audrins MS, Saunders D, Quinn F, de Kretser D et al. (2000) Y chromosome analysis of infertile men and their sons concieved through intracytoplasmic sperm injection: Vertical transmission of deletions and rarity of de novo deletions. Fertil Steril 5,909-915.
7. Dearnaley D, Huddart R and Horwich A (2001) Regular review: Managing testicular cancer. BMJ 322,1583-1588.
8. De Mas P, Daudin M, Vincent MC, Bourrouillou G, Calvas P, Mieusset R and Bujan L (2001) Increased aneuploidy in spermatozoa from testicular tumour patients after chemotherapy with cisplatin, etoposide and bleomycin. Hum Reprod 16,1204-1208.
9. Dubrova YE (2003) Long-term genetic effects of radiation exposure. Mutat Res 544,433-439.
10. Eberhard J, Stahl O, Giwercman Y, Cwikiel M, Cavallin-Stahl E, Lundin KB, Flodgren P and Giwercman A (2004) Impact of therapy and androgen receptor polymorphism on sperm concentration in men treated for testicular germ cell cancer: A longitudinal study. Hum Reprod 19,1418-1425.
11. Erenpreiss J, Jepson K, Giwercman A, Tsarev I, Erenpreisa J and Spano M (2004) Toluidine blue cytometry test for sperm DNA conformation: comparison with the flow cytometric sperm chromatin structure and TUNEL assays. Hum Reprod 19(10),2277-2282.
12. Evenson DP, Larson KL and Jost LK (2002) Sperm chromatin structure assay: Its clinical use for detecting sperm DNA fragmentation in male infertility and comparisons with other techniques. J Androl 23,25-43.
13. Fosså SD, De Angelis P, Kraggerud SM, Evenson D, Theodorsen L and Clausen OPF (1997) Prediction of posttreatment spermatogenesis in patients with testicular cancer by flow cytometric sperm chromatin assay. Cytometry 30,192-196.
14. Frias S, Van Hummelen P, Meistrich M, Lowe X, Hagemeister FB, Shelby MD, Bishop J and Wyrobek AJ (2003) NOVP chemotherapy for Hodgkin's disease transiently induces sperm aneuploidies associated with the major clinical aneuploidy syndromes involving chromosomes X, Y,18 and 21. Cancer Res 63,44-51.
15. Gandini L, Lombardo F, Paoli D, Caponecchia L, Familiari G, Verlengia C, Dondero F and Lenzi A (2000) Study of apoptotic DNA fragmentation in human spermatozoa. Hum Reprod 15,830-839.
16. Hales BF, Barton TS and Robaire B (2005) Impact of Paternal Exposure to Chemotherapy on Offspring in the Rat. J Natl Cancer Inst Monogr 34,28-31.
17. Klepp O, Dahl O, Flodgren P, Stierner U, Olsson AM, Oldbring J, Nielsson S, Daehlin L, Tornblom M, Smaland R et al. (1997) Risk-adapted treatment of clinical stage I non-seminoma testis cancer. Eur J Cancer 7,1038-1044.
18. Kobayashi H, Larson K, Sharma RK, Nelson DR, Evenson D, Torna H, Thomas Jr AJ and Agarwal A (2001) DNA damage in patients with untreated cancer as measured by sperm chromatin structure assay. Fertil Steril 75,469-475.
19. Laguna MP, Pizzocaro G, Klepp O, Algaba F, Kisbenedek L and Leiva O (2001) EAU guidelines on testicular cancer. Eur Urol 40,102-110.
20. Larson KI, DeJonge CJ, Barnes AM, Jost LK and Evenson DP (2000) Sperm chromatin structure assay parameters as predictors of failed pregnancy following assisted reproductive techniques. Hum Reprod 15,1717-1722.
21. Larson KI, DeJonge CJ, Barnes AM, Jost LK and Evenson DP (2001) Sperm chromatin structure assay parameters as predictors of failed pregnancy following assisted reproductive techniques. Hum Reprod 15,1717-1722.
22. Marchetti F, Bishop JB, Lowe X, Generoso WM, Hozier J and Wyrobek AJ (2001) Etoposide induces heritable chromosomal aberrations and aneuploidy during male meiosis in the mouse. Proc Natl Acad Sci USA 98(7),3952-3957.
23. Martin R, Ernst S, Rademeker A, Barclay L, Ko E and Summers N (1997) Chromosomal abnormalities in sperm from testicular cancer patients before and after chemotherapy. Hum Genet 99,214-218.
24. Meistrich ML and Byrne J (2002) Genetic disease in offspring of long-term survivors of childhood and adolescent cancer treated with potentially mutagenic therapies. Am J Hum Genet 70,1069-1071.
25. Morris ID (2002) Sperm DNA damage and cancer treatment. Int J Androl 25,255-261.
26. O'Donovan M (2005) An evaluation of chromatin condensation and DNA integrity in the spermatozoa of men with cancer before and after therapy. Andrologia 37,83-90.
27. Perreault SD, Aitken RJ, Baker HW, Evensson DP, Huszar G, Irvine DS, Morris ID, Morris RA, Robbins W, Sakkas D et al. (2003) Integrating new tests of sperm genetic integrity into semen analysis: Breakout group discussion. Adv Exp Med Biol 518,253-268.
28. Petersen PM, Giwercman A, Skakkebæk NE and Rørth M (1998) Gonadal function in men with testicular cancer. Semin Oncol 25,224-234.
29. Richthoff J, Spano M, Giwercman YL, Frohm B, Jepson K, Malm JEI, Zanaty S, Stridsberg M and Giwercman A (2002) The impact of testicular and accessory sex gland function on sperm chromatin integrity as assessed by sperm chromatin structure assay (SCSA). Hum Reprod 17,3162-3169.
30. Sakkas D, Moffatt O, Manicardi GC, Mariethoz E, Tarozzi N and Bizzaro D (2002) Nature of DNA damage in ejaculated human spermatozoa and the possible involvement of apoptosis. Biol Reprod 66,1061-1067.
31. Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J, Kollmannsberger C, Fossa SD, Skakkebaek NE, de Wit R, Fizazi K et al. (2004) European consensus on diagnosis and treatment of germ cell cancer: A report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 15,1377-1399.
32. Sjoblom T, West A and Lahdetie J (1998) Apoptotic response of spermatogenic cells to the germ cell mutagens etoposide, adriamycin, and diepoxybutane. Environ Mol Mutagen 31(2),133-148.
33. Spano M, Kolstad AH, Larsen SB, Cordelli E, Leter G, Giwercman A and Bonde JP (1998) The applicability of the flow cytometric sperm chromatin structure assay as diagnostic and prognostic tool in then human fertility clinic. Hum Reprod 13,2495-2505.
34. Stahl O, Eberhard J, Jepson K, Spano M, Cwikiel M, Cavallin-Stahl E and Giwercman A (2004) The impact of testicular carcinoma and its treatment on sperm DNA integrity. Cancer 100,1137-1144.
35. Stumpp T, Sasso-Cerri E, Freymuller E and Miraglia SM (2004) Apoptosis and testicular alterations in albino rats treated with etoposide during the prepubertal phase. Anat Rec A Discov Mol Cell Evol Biol 279,611-622.
36. Tawn EJ, Whitehouse CA, Winther JF, Curwen GB, Rees GS, Stovall M, Olsen JH, Guldberg P, Rechnitzer C, Schroder H et al. (2005) Chromosome analysis in childhood cancer survivors and their offspring - no evidence for radiotherapy-induced persistent genomic instability. Mutat Res 583(2),198-206.
37. Thomas C, Cans S, Pelletier R, De Robertis C, Hazzouri M, Sele B, Rousseaux S and Hennebicq S (2004) No long-term increase in sperm aneuploidy rates after anticancer therapy: Sperm fluorescence in situ hybridization analysis in 26 patients treated for testicular cancer or lymphoma. Clin Cancer Res 10(19),6535-6543.
38. Thomson AB, Campbell AJ, Irvine DC, Anderson RA, Kelnar C and Wallace WH (2002) Semen quality and spermatozoal DNA integrity in survivors of childhood cancer: A case-control study. Lancet 360,361-367.
39. Witt KL and Bishop JB (1996) Mutagenicity of anticancer drugs in mammalian germ cells. Mutat Res 355,209-234.
40. World Health Organization (1999) WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. Cambridge University Press, Cambridge.
41. Zhang X, Yamamoto N, Soramoto S and Takenaka I (2001) Cisplatin-induced germ cell apoptosis in mouse testes. Arch Androl 46(1),43-49.